ANVS
Annovis Bio, Inc.
NYSE · USHealthcareBiotechnology
$1.69-3.16%
Price as of Jul 20, 2026
ANVS earnings
Annovis Bio, Inc. earnings
Reported EPS and revenue history, upcoming estimates and available earnings-call summaries.
Next earnings
Aug 11, 2026in NaN days
EPS est $-0.44 · Revenue est —
Track record
Beat EPS in 4 of 12 quarters
Avg surprise -19.4% (last 4 quarters)
Earnings history
| Report date | EPS est | EPS actual | Surprise | Revenue | Rev. surprise |
|---|---|---|---|---|---|
| May 15, 2026 | $-0.40 | $-0.63 | -59.5% | — | — |
| Mar 16, 2026 | $-0.31 | $-0.39 | -26.5% | — | — |
| Nov 12, 2025 | $-0.36 | $-0.37 | -2.8% | — | — |
| Aug 12, 2025 | $-0.36 | $-0.32 | +11.1% | — | — |
| Mar 21, 2025 | $-0.38 | $-0.43 | -13.2% | — | — |
| Nov 8, 2024 | $-0.53 | $-0.97 | -83.0% | — | — |
| Aug 14, 2024 | $-0.63 | $-0.44 | +30.2% | — | — |
| Mar 29, 2024 | $-1.35 | $-1.09 | +19.3% | — | — |
| Aug 15, 2023 | $-1.14 | $-1.07 | +6.1% | — | — |
| May 11, 2023 | $-0.85 | $-1.19 | -40.0% | — | — |
| May 4, 2022 | $-0.58 | $-0.72 | -24.1% | — | — |
| Mar 2, 2022 | $-0.25 | $-0.75 | -200.0% | — | — |
Earnings history is derived from company filings and calendar data. Call summaries are grouped by reporting period. Latest covered event: 2026-08-11.